How much does Ogivri (trastuzumab-dkst) cost?
Ogivri (trastuzumab-dkst) pricing isn’t fixed and depends on your country, insurance status, and whether you’re paying cash or using a patient assistance program. The drug’s cost also varies by dose and treatment schedule because Ogivri is given by intravenous infusion, with dosing based on body weight for many regimens.
What affects Ogivri’s out-of-pocket price?
Your Ogivri cost typically changes with:
- Insurance coverage (commercial insurance vs. Medicare/Medicaid)
- Your plan’s formulary status (preferred/non-preferred)
- Whether your infusion center bills separately for the drug vs. administration fees
- Your deductible/coinsurance and whether you’ve met them yet
- Dose size and number of infusions in your treatment plan
Are there cheaper alternatives to Ogivri?
Depending on your situation, options may include:
- Other trastuzumab products (biosimilars or reference products), if covered by your plan
- Switching within the same active ingredient class if your oncology team and payer approve it
Prices can differ substantially between products and between payers.
Are there patient assistance programs for Ogivri?
Cost support can be available through manufacturer programs, foundations, or copay cards (where eligibility allows). Eligibility rules vary by insurance type, income, and whether you’re enrolled in government programs.
If you want a specific Ogivri cost, what should you provide?
If you share your country, insurance type (commercial/Medicare/Medicaid/uninsured), and the dosing schedule you’ve been prescribed (or your weight and regimen), I can help estimate what components usually drive the total cost and what to ask your insurer/infusion provider.
Sources
No sources were provided.